Showing results (531-540 of 12,568) with videos related to
Sort By:
Pageof 1,257
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2026
Anti-PD-L1 biomimetic nanobubbles for ultrasound-triggered reprogramming of cold hepatocellular carcinoma for immunotherapyHaibin Tu, Yanbing Cao, Xinyi Lin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel diseaseSunil Kumar Sah, Mamta Kumari, Lohare Rahul Sanjay, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Long-acting nanomedicine for brain diseasesJun Liao, Qi Huang, Ruiyu Li, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2026
Dual-biomimetic Nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repairPeng Wang, Ruobing Li, Jinjin Ni, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 16, 2026
Engineered virus-derived platform enables glutathione depletion and cuproptosis for enhanced cancer immunotherapyPengkai Wu, Xuesong Wu, Mengshuang Li, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 27, 2025
A fusion protein that targets antigen-loaded extracellular vesicles to B cells enhances antigen-specific T cell expansionAnnemarijn Offens, Loes Teeuwen, Gozde Gucluler Akpinar, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 27, 2025
A "three-in-one" thermosensitive gel system that enhances mucus and biofilm penetration for the treatment of vulvovaginal candidiasisYameng Wang, Zhiyuan Wang, Qibin Li, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2025
Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generationYang Li, Yulin Yu, Bin Xia, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2025
Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosisHuijuan Zhang, Yingmei Tian, Yan Ren, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2025
Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancerJiadong Pang, Xiaoyu Chen, Zhijun Lin, et al.Pageof 1,257